Search

Author/Creator Jedema, I.

1. 36MO Location and size of metastasectomy in melanoma patients treated with tumor-infiltrating lymphocytes (TIL) in relation to clinical outcome. (December 2022)

Authors:
Rohaan, M.; Holz Borch, T.; Kessels, R.; Nijenhuis, C.; van den Berg, J.H.; Nuijen, B.; Jedema, I.; van Zon, M.; Geukes Foppen, M.; Torres Acosta, A.; Wilgenhof, S.; Lalezari, F.; Rosenkrantz Hölmich, L.; Van Houdt, W.; Wouters, M.; van Akkooi, A.C.J.; Met, Ö.; Donia, M.; Svane, I-M.; Haanen, J.B...
Journal:
Immuno-oncology technology
Issue:
Volume 16(2022)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 43P Development of a production process to generate CD8+ T cell-enriched tumor-nfiltrating lymphocyte (TIL) products with increased cytotoxic potential for the treatment of patients with solid cancers. (December 2022)

Authors:
Tas, L.; van Zon, M.; Djuretic, I.; Moynihan, K.D.; Yeung, Y.A.; Mathewson, N.; Haanen, J.B.A.G.; Jedema, I.
Journal:
Immuno-oncology technology
Issue:
Volume 16(2022)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. 8P Phenotypic characterization of infused tumor-infiltrating lymphocytes (TIL) correlates with response to adoptive cellular therapy (ACT) in patients with metastatic melanoma (MM). (December 2022)

Authors:
Stoltenborg Granhøj, J.; Rohaan, M.; Holz Borch, T.; Presti, M.; Nijenhuis, C.; van Zon, M.; Jedema, I.; Nuijen, B.; Kessels, R.; Torres Acosta, A.; Lalezari, F.; van den Berg, J.; Donia, M.; Haanen, J.B.A.G.; Svane, I-M.
Journal:
Immuno-oncology technology
Issue:
Volume 16(2022)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Leflunomide as part of the treatment for multidrug‐resistant cytomegalovirus disease after lung transplantation: case report and review of the literature. Issue 6 (23rd October 2013)

Authors:
Verkaik, N.J.; Hoek, R.A.S.; van, H.; van, P.Th.W.; Schipper, M.E.I.; Pas, S.D.; Beersma, M.F.C.; Boucher, C.A.B.; Jedema, I.; Falkenburg, F.; Hoogsteden, H.C.; van den, B.; Murk, J.L.
Journal:
Transplant infectious disease
Issue:
Volume 15:Issue 6(2013)
Page Start:
E243
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. MART-1 TCR gene-modified peripheral blood T cells for the treatment of metastatic melanoma: a phase I/IIa clinical trial. (September 2022)

Authors:
Rohaan, M.W.; Gomez-Eerland, R.; van den Berg, J.H.; Geukes Foppen, M.H.; van Zon, M.; Raud, B.; Jedema, I.; Scheij, S.; de Boer, R.; Bakker, N.A.M.; van den Broek, D.; Pronk, L.M.; Grijpink-Ongering, L.G.; Sari, A.; Kessels, R.; van den Haak, M.; Mallo, H.A.; Karger, M.; van de Wiel, B.A.; Zuur,...
Journal:
Immuno-oncology technology
Issue:
Volume 15(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗